202 related articles for article (PubMed ID: 16051735)
21. Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression.
Janssen HL; Higuchi H; Abdulkarim A; Gores GJ
J Hepatol; 2003 Sep; 39(3):414-20. PubMed ID: 12927928
[TBL] [Abstract][Full Text] [Related]
22. Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1.
MacFarlane M; Inoue S; Kohlhaas SL; Majid A; Harper N; Kennedy DB; Dyer MJ; Cohen GM
Cell Death Differ; 2005 Jul; 12(7):773-82. PubMed ID: 15861184
[TBL] [Abstract][Full Text] [Related]
23. Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Schneider P; Olson D; Tardivel A; Browning B; Lugovskoy A; Gong D; Dobles M; Hertig S; Hofmann K; Van Vlijmen H; Hsu YM; Burkly LC; Tschopp J; Zheng TS
J Biol Chem; 2003 Feb; 278(7):5444-54. PubMed ID: 12466268
[TBL] [Abstract][Full Text] [Related]
24. Expression of tumor necrosis factor- alpha -related apoptosis-inducing ligand and its proapoptotic receptors is down-regulated during gastric infection with virulent cagA+/vacAs1+ Helicobacter pylori strains.
Neu B; Rad R; Reindl W; Neuhofer M; Gerhard M; Schepp W; Prinz C
J Infect Dis; 2005 Feb; 191(4):571-8. PubMed ID: 15655781
[TBL] [Abstract][Full Text] [Related]
25. Rare loss-of-function mutation of a death receptor gene in head and neck cancer.
Pai SI; Wu GS; Ozören N; Wu L; Jen J; Sidransky D; El-Deiry WS
Cancer Res; 1998 Aug; 58(16):3513-8. PubMed ID: 9721851
[TBL] [Abstract][Full Text] [Related]
26. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family.
Degli-Esposti MA; Smolak PJ; Walczak H; Waugh J; Huang CP; DuBose RF; Goodwin RG; Smith CA
J Exp Med; 1997 Oct; 186(7):1165-70. PubMed ID: 9314565
[TBL] [Abstract][Full Text] [Related]
27. Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.
Tang X; Wu W; Sun SY; Wistuba II; Hong WK; Mao L
Mol Cancer Res; 2004 Dec; 2(12):685-91. PubMed ID: 15634757
[TBL] [Abstract][Full Text] [Related]
28. Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer.
Fisher MJ; Virmani AK; Wu L; Aplenc R; Harper JC; Powell SM; Rebbeck TR; Sidransky D; Gazdar AF; El-Deiry WS
Clin Cancer Res; 2001 Jun; 7(6):1688-97. PubMed ID: 11410508
[TBL] [Abstract][Full Text] [Related]
29. In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activity.
Wuchter C; Krappmann D; Cai Z; Ruppert V; Scheidereit C; Dörken B; Ludwig WD; Karawajew L
Leukemia; 2001 Jun; 15(6):921-8. PubMed ID: 11417478
[TBL] [Abstract][Full Text] [Related]
30. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM
Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
[TBL] [Abstract][Full Text] [Related]
31. Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas.
Mestre-Escorihuela C; Rubio-Moscardo F; Richter JA; Siebert R; Climent J; Fresquet V; Beltran E; Agirre X; Marugan I; Marín M; Rosenwald A; Sugimoto KJ; Wheat LM; Karran EL; García JF; Sanchez L; Prosper F; Staudt LM; Pinkel D; Dyer MJ; Martinez-Climent JA
Blood; 2007 Jan; 109(1):271-80. PubMed ID: 16960149
[TBL] [Abstract][Full Text] [Related]
32. Expression of TRAIL and its receptors in human brain tumors.
Frank S; Köhler U; Schackert G; Schackert HK
Biochem Biophys Res Commun; 1999 Apr; 257(2):454-9. PubMed ID: 10198234
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines.
Shetty S; Gladden JB; Henson ES; Hu X; Villanueva J; Haney N; Gibson SB
Apoptosis; 2002 Oct; 7(5):413-20. PubMed ID: 12207174
[TBL] [Abstract][Full Text] [Related]
34. TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections.
Sträter J; Walczak H; Pukrop T; Von Müller L; Hasel C; Kornmann M; Mertens T; Möller P
Gastroenterology; 2002 Mar; 122(3):659-66. PubMed ID: 11874999
[TBL] [Abstract][Full Text] [Related]
35. Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity.
Mirandola P; Ponti C; Gobbi G; Sponzilli I; Vaccarezza M; Cocco L; Zauli G; Secchiero P; Manzoli FA; Vitale M
Blood; 2004 Oct; 104(8):2418-24. PubMed ID: 15205263
[TBL] [Abstract][Full Text] [Related]
36. Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D.
Olsson A; Diaz T; Aguilar-Santelises M; Osterborg A; Celsing F; Jondal M; Osorio LM
Leukemia; 2001 Dec; 15(12):1868-77. PubMed ID: 11753607
[TBL] [Abstract][Full Text] [Related]
37. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells.
Secchiero P; Milani D; Gonelli A; Melloni E; Campioni D; Gibellini D; Capitani S; Zauli G
J Leukoc Biol; 2003 Aug; 74(2):223-32. PubMed ID: 12885939
[TBL] [Abstract][Full Text] [Related]
39. Sensitivity to TRAIL/APO-2L-mediated apoptosis in human renal cell carcinomas and its enhancement by topotecan.
Déjosez M; Ramp U; Mahotka C; Krieg A; Walczak H; Gabbert HE; Gerharz CD
Cell Death Differ; 2000 Nov; 7(11):1127-36. PubMed ID: 11139287
[TBL] [Abstract][Full Text] [Related]
40. Expression of TNF-related apoptosis inducing ligand (TRAIL) on infiltrating cells and of TRAIL receptors on salivary glands in patients with Sjögren's syndrome.
Matsumura R; Umemiya K; Kagami M; Tomioka H; Tanabe E; Sugiyama T; Sueishi M; Kayagaki N; Yagita H; Okumura K
Clin Exp Rheumatol; 2002; 20(6):791-8. PubMed ID: 12508770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
